发明名称 |
RELAXIN FOR TREATING PATIENTS AFFLICTED OF IMPAIRED GLUCOSE TOLERANCE |
摘要 |
A pharmaceutical composition for treatment for of r afflicted or in risk of becoming of impaired glucose tolerance (IGT) and/or type-2 it comprising an effective amount of relaxin for protecting beta-cells and beta-cell function against the effects of high blood glucose (glucotoxicity). Treatment of persons of disglycaemias, and protection of beta cells of the islets of Langerhans and beta-cell function in patients having type-2 diabetes, is diclosed. |
申请公布号 |
US2015038411(A1) |
申请公布日期 |
2015.02.05 |
申请号 |
US201314380163 |
申请日期 |
2013.02.22 |
申请人 |
Dschietzig Thomas |
发明人 |
Dschietzig Thomas |
分类号 |
A61K38/22 |
主分类号 |
A61K38/22 |
代理机构 |
|
代理人 |
|
主权项 |
1. A pharmaceutical composition for treatment of a person afflicted of impaired glucose tolerance or in high risk of becoming afflicted of impaired glucose tolerance followed by type-2 diabetes comprising an effective amount of relaxin peptides for protecting beta-cells and beta-cell function against the toxic effects of high blood glucose levels. |
地址 |
Berlin DE |